Investigation of synergy between novel B-cell receptor targeting agents and DNA damage repair inhibitors in chronic lymphocytic leukemia
dc.contributor.author | Brown, Jennifer | |
dc.date.accessioned | 2018-10-02T19:37:43Z | |
dc.date.available | 2018-10-02T19:37:43Z | |
dc.date.issued | 2018-08-23 | |
dc.date.submitted | 2018-10-02T19:37:43Z | en |
dc.description.sponsorship | H.T Thorlakson Foundation Dean, College of Medicine Research Manitoba Manitoba Medical Service Foundation (MMSF) Vice Dean Research Rady FHS | en_US |
dc.identifier.citation | AMA | en_US |
dc.identifier.uri | http://hdl.handle.net/1993/33499 | |
dc.rights | open access | en_US |
dc.subject | Chronic lymphocytic leukemia (CLL) | en_US |
dc.subject | anti-CD20 antibody | en_US |
dc.subject | Bruton Tyrosine Kinase | en_US |
dc.title | Investigation of synergy between novel B-cell receptor targeting agents and DNA damage repair inhibitors in chronic lymphocytic leukemia | en_US |
dc.type | bachelor thesis | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Brown_BSc(Med) Report.pdf
- Size:
- 2.03 MB
- Format:
- Adobe Portable Document Format
- Description:
- BSc(Med) Final Research Report
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: